China
Africa
Loading...
- 3F8
- Abciximab
- Abdala
- Abzymes
- Accessory cell
- Acquired ichthyosis
- Acquired immunity
- Active immunity
- Acute disseminated encephalomyelitis
- Acute inflammation
- Acute organ rejection
- Acute pyelonephritis
- Acute rejection
- Adaptive immune system
- Adaptive immunity
- ADE
- Adenoiditis
- Adipocytokine
- Adipokines
- Adipose tissue macrophages
- Adoptive immunity
- Affinity maturation
- Agglutination
- Agglutination tests
- Agglutinin
- Aggrecan
- Agranulocytes
- AHCC
- Alarmin
- Aldesleukin
- Alirocumab
- Allergenicity
- Allergens
- Allergic disease
- Allergic reaction
- Allergies
- Allergy
- Alloantibody
- Alloantigen
- Alloimmune
- Alloimmunity
- Alloimmunization
- Allorecognition
- Alpha 1 microglobulin
- Alpha defensin
- Alpha-1-microglobulin
- Alternative complement pathway
- Alveolar macrophages
- Amnionitis
- ANA
- Anaphylatoxins
- Anergy
- Angioimmunoblastic T-cell lymphoma
- Animal allergy
- Anterior uveitis
- Anthrax immune globulin
- Anti thymocyte globulin
- Anti-CD3 monoclonal antibody
- Anti-DNase B
- Anti-gliadin antibodies
- Anti-immunoglobulin
- Anti-lymphocyte globulin
- Anti-saccharomyces cerevisiae antibody
- Anti-thymocyte globulin
- Antiallergic
- Antibodies
- Antibody
- Antibody engineering
- Antibody opsonization
- Antibody response
- Antibody titer
- Antigen antibody reactions
- Antigen presentation
- Antigen presenting cells
- Antigen processing
- Antigen recognition
- Antigen-presenting cells
- Antigenic variation
- Antigenicity
- Antiglomerular basement membrane disease
- Antimicrobial peptides
- Antinuclear antibody
- Antisperm antibodies
- Antistreptolysin
- Antitoxins
- Apolipoprotein H
- Apoptotic DNA fragmentation
- Arthus reaction
- Asialoglycoprotein receptor
- ASO
- Asplenia
- Atrophic rhinitis
- Autoantibodies
- Autoantibody
- Autoantigens
- Autoimmune
- Autoimmune diseases
- Autoimmune encephalitis
- Autoimmune enteropathy
- Autoimmune inner ear disease
- Autoimmune regulator
- Autoimmunity
- Autoinflammatory
- Autoinflammatory disease
- Autoinflammatory syndrome
- Autoinflammatory syndromes
- B cell receptor
- B cells
- B lymphocytes
- B-cell receptor
- B-cells
- Bacterial keratitis
- BALT
- Behavioral immune system
- Beta defensin
- Beta defensin 1
- Beta defensin 2
- Beta-defensin 2
- Beta-lactoglobulin
- Bezlotoxumab
- bi-specific T-cell engager
- Bimagrumab
- Bimekizumab
- Biological response modifiers
- Bispecific antibodies
- Bispecific antibody
- Bispecific monoclonal antibody
- Bivatuzumab
- Blocking antibody
- Blood serum
- Bone marrow derived macrophages
- Bone marrow-derived macrophages
- Breakthrough infection
- Bullous pemphigoid
- bursa of Fabricius
- Bursitis
- C1 complex
- C1-inhibitor
- C1q
- C1R
- C1s
- C3 convertase
- C3-convertase
- C3a
- C3b
- C5-convertase
- C5a
- C8 complex
- Calcific tendinitis
- Calreticulin
- Camrelizumab
- Castleman disease
- Castleman's disease
- Cathelicidin
- CC chemokine receptors
- CCL11
- Ccl12
- CCL16
- CCL17
- CCL19
- CCL2
- CCL20
- CCL21
- CCL22
- CCL23
- CCL24
- CCL25
- CCL26
- CCL27
- CCL28
- CCL3
- CCL5
- CCL8
- CCL9
- CCR1
- CCR10
- CCR2
- CCR3
- CCR4
- CCR5
- CCR8
- CCR9
- CD123
- CD127
- CD134
- CD21
- CD23
- CD3
- CD4 CD8 ratio
- CD8
- CD8+ cell
- CD8+ T lymphocyte
- Cecropin
- Celiac disease
- Cell mediated immunity
- Cellular immune response
- Cellular immunity
- Central tolerance
- Centroblasts
- Centrocytes
- Cervicitis
- CH50
- Chemokines
- Cholera vaccine
- Chorioamnionitis
- Chronic deciduitis
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic inflammation
- Chronic inflammatory demyelinating polyneuropathy
- Chronic pyelonephritis
- Chronic rejection
- Chronic tonsillitis
- Class switch recombination
- Classical complement pathway
- Classical pathway
- Clec7a
- Clinical immunology
- Clonal anergy
- Clonal deletion
- Clonal selection
- CMKLR1
- Co-stimulation
- Coeliac disease
- Coelomocytes
- Cold agglutinin
- Colony stimulating factor
- Colony stimulating factor receptor
- Colony-stimulating factor
- Common gamma chain
- Complement
- Complement activation
- Complement cascade
- Complement component 3
- Complement component 5
- Complement control protein
- Complement dependent cytotoxicity
- Complement factor
- Complement factor B
- Complement factor D
- Complement factor H
- Complement factor I
- Complement membrane attack complex
- Complement receptor 2
- Complement receptors
- Complement system
- Complementarity determining region
- Complementarity determining regions
- Condensing osteitis
- Constrictive pericarditis
- Contact allergen
- Coronavac
- Counter immunoelectrophoresis
- Counterimmunoelectrophoresis
- COVI-VAC
- CR6261
- CRABP1
- CRABP2
- Crenezumab
- Cross presentation
- Cross reaction
- Cross reactivity
- Cross-presentation
- Cross-reactivity
- Cryofibrinogenemia
- Cryoglobulin
- Cryptitis
- Cutaneous lymphoma
- CX3CL1
- CXC chemokine receptors
- CXCL1
- CXCL10
- CXCL11
- CXCL13
- CXCL14
- CXCL16
- CXCL2
- CXCL3
- CXCL5
- CXCL6
- CXCL9
- CXCR2
- CXCR4
- CXCR7
- Cyclic neutropenia
- Cystic lymphangioma
- Cytokine
- Cytokine release syndrome
- Cytokine storm
- Cytokine storm syndrome
- Cytokines
- Cytotoxic T cells
- Cytotoxic T lymphocytes
- Cytotoxic T-cells
- Daclizumab
- Dacryoadenitis
- Dactylitis
- Danger model
- Daunosamine
- Death receptor
- Dectin 1
- Defensins
- Demcizumab
- Dendritic cells
- Dermal macrophage
- Dermcidin
- Desosamine
- Diabetes mellitus type 1
- Diabody
- Dietary inflammatory index
- Dioxin
- Dioxins and dioxin-like compounds
- Discoid lupus erythematosus
- Donor-specific antibody
- Ectopic thymus
- Edema
- Empyema
- Endocarditis
- Endometritis
- Enoblituzumab
- Enteritis
- Enterocolitis
- Enteropathy-associated T-cell lymphoma
- Eosinophilic fasciitis
- Eotaxin 2
- Eotaxin 3
- Epicondylitis
- Epiploic appendagitis
- Epitope mapping
- Epstein-Barr virus nuclear antigen 1
- Erythropoietin
- Esophagitis
- Etrolizumab
- Extracutaneous mastocytoma
- Factor B
- Factor D
- Factor H
- Fasciitis
- Fc receptor
- FCER1A
- FCGR1A
- FCRL3
- FCRN
- FcεRI
- FI6
- Fibroblast-like synoviocyte
- Fluid retention
- FMS-like tyrosine kinase 3 ligand
- Foam cells
- Follicular B cells
- Follicular B helper T cells
- Follicular dendritic cells
- Foreign body granuloma
- Foreign body reactions
- Forssman antigen
- Fragment antigen binding
- Fresolimumab
- Freunds adjuvant
- Galactosamine
- GALT
- Gamma delta T cells
- Gammadelta T cells
- Gantenerumab
- Germinal centers
- Germinal centres
- Gingivitis
- Glomerulonephritis
- Glycodelin
- Glymphatic system
- Glypican 3
- GM-CSF
- Goodpasture syndrome
- Graft rejection
- Graft-versus-host disease
- Granulocyte
- Granulocyte-macrophage colony-stimulating factor
- Granulocytopenia
- Graves' disease
- Gum disease
- Guselkumab
- Haptens
- Hashimoto's encephalopathy
- HBx
- Heaf test
- Heavy chain antibody
- Heavy chain disease
- Heavy chains
- Helicase-primase complex
- Helper T cells
- Hereditary gingival fibromatosis
- Herpesvirus entry mediator
- Herpetic gingivostomatitis
- Herpetic stomatitis
- Heterophile antibody
- Heterosubtypic immunity
- Histocompatibility
- HLA B27
- HLA-B27
- Human anti-mouse antibody
- Humanized antibody
- Humoral immunity
- HY antigen
- Hypersensitive response
- IC3b
- Idiopathic CD4+ lymphocytopenia
- Idiotype
- IgA
- IgG4-related disease
- IGH
- IL-10
- IL-10 family
- IL-12 receptor
- IL-15 receptor
- IL-1α
- IL-1β
- IL-2 receptor
- IL-34
- IL-5 receptor
- Il2rg
- IL6R
- IL7R
- ILC2s
- Ileitis
- Immune adherence
- Immune checkpoint
- Immune complexes
- Immune disorders
- Immune dysregulation
- Immune evasion
- Immune function
- Immune privilege
- Immune repertoire
- Immune system
- Immune tolerance
- Immune-mediated inflammatory diseases
- Immune-related response criteria
- Immunity
- Immunization
- Immunoadsorption
- Immunoblast
- Immunochemistry
- Immunocompetence
- Immunoconjugates
- Immunodominance
- Immunoediting
- Immunogen
- Immunogenicity
- Immunoglobulin
- Immunoglobulin A
- Immunoglobulin class switching
- Immunoglobulin heavy chain
- Immunoglobulin light chains
- Immunoglobulin superfamily
- Immunoglobulins
- Immunolabeling
- Immunologic memory
- Immunological memory
- Immunological synapse
- Immunological tolerance
- Immunology
- Immunomics
- Immunomodulation
- Immunoproteomics
- Immunoreceptor tyrosine-based inhibitory motif
- Immunoregulation
- Immunosenescence
- Immunostaining
- Immunostimulant
- Immunosuppression
- Immunosurveillance
- Immunotoxins
- Inactivated vaccine
- Inactivated virus vaccine
- Inflammation
- Inflammatory bowel disease
- Inflammatory cell
- Inflammatory cytokines
- Inflammatory diseases
- Inflammatory disorder
- Inflammatory mediators
- Inflammatory reflex
- Inflammatory response
- Inguinal lymphadenopathy
- Innate immune cells
- Innate immune responses
- Innate immune system
- Innate immunity
- Innate lymphoid cells
- Inoculation
- Inoculum
- Insulin dependent diabetes mellitus
- Interdigitating dendritic cell sarcoma
- Interferon
- Interferon beta-1b
- Interferon gamma release assay
- Interferon stimulated gene factor 3
- Interferons
- Interleukin
- Interleukin 1
- Interleukin 1 receptor antagonist
- Interleukin 1-alpha
- Interleukin 10
- Interleukin 11
- Interleukin 12
- Interleukin 13
- Interleukin 15
- Interleukin 17
- Interleukin 18
- Interleukin 1beta
- Interleukin 2
- Interleukin 2 receptor
- Interleukin 21
- Interleukin 22
- Interleukin 23
- Interleukin 25
- Interleukin 3
- Interleukin 31
- Interleukin 32
- Interleukin 33
- Interleukin 36
- Interleukin 5
- Interleukin 6
- Interleukin 7
- Interleukin 8
- Interleukin-23 receptor
- Interleukin-3 receptor
- Interleukin-5 receptor
- Interleukin-7 receptor
- Interleukin-7 receptor-α
- Interleukins
- Intrabody
- Intraepithelial lymphocytes
- IRGs
- Iridocyclitis
- Iritis
- ISCOM
- Isoantibodies
- Isograft
- Isotypes
- Japanese encephalitis vaccine
- Junctional diversity
- Kawasaki disease
- Kawasaki syndrome
- Keratitis
- Kidney infection
- Labyrinthitis
- LANA
- Large granular lymphocyte
- Latent tuberculosis
- LE cell
- Lectin pathway
- Lenzilumab
- Leukemia cutis
- Leukocyte count
- Leukocyte immunoglobulin-like receptors
- Leukocytes
- Leukoderma
- LFA-1
- LIF
- Light chain
- Linear epitope
- Linear scleroderma
- Lipocalin
- Long-lived plasma cells
- LOX1
- Lupus erythematosus
- Lymph duct
- Lymph nodes
- Lymph sacs
- Lymph vessels
- Lymphangiogenesis
- Lymphangioleiomyomatosis
- Lymphangiomas
- Lymphangion
- Lymphatic disease
- Lymphatic drainage
- Lymphatic endothelium
- Lymphatic system
- Lymphatic tissue
- Lymphatic tissues
- Lymphatic vessels
- Lymphocyte
- Lymphocyte activation
- Lymphocyte count
- Lymphocytic colitis
- Lymphocytic infiltration
- Lymphoid cells
- Lymphoid tissue
- Lymphoid tissues
- Lymphokines
- Lymphomatoid granulomatosis
- Lymphomatoid papulosis
- Lymphopoiesis
- Lymphoproliferative response
- Lymphotoxin
- Lymphotoxin alpha
- Macrophage activation
- Macrophage inflammatory protein
- Macrophage migration inhibitory factor
- Macrophage polarization
- Macrophage-activating factor
- Macrophages
- Magainin
- Malignant histiocytosis
- MALT
- Mannosamine
- Mannose receptor
- Mantoux test
- Marginal zone B cells
- MASP1
- MASP2
- Mast cell activation syndrome
- Mastoiditis
- Mavrilimumab
- Medullary thymic epithelial cells
- Megakaryoblast
- Meglumine
- Melittin
- Membrane attack complex
- Membranous glomerulonephritis
- Membranous nephropathy
- Memory B cells
- Memory cells
- Memory T cells
- Meningeal lymphatic vessels
- Metelimumab
- MHC class III
- MHC restriction
- Microchimerism
- Microglia
- Microglial cells
- Milatuzumab
- Milky spots
- Mimotope
- Mixed lymphocyte reaction
- MOG antibody disease
- Mogamulizumab
- Molecular mimicry
- Monoblasts
- Monoclonal antibodies
- Monoclonal antibody
- Monoclonal antibody therapy
- Monocytes
- Monokines
- Mononuclear cell infiltration
- Mononuclear cells
- Mononuclear phagocyte system
- Mononuclear phagocytes
- MS4A2
- Mucosa-associated lymphoid tissue
- Mucosal immunity
- Mucosal immunology
- Mucosal-associated invariant T cells
- Multiple sclerosis
- Multiple Sclerosis Functional Composite
- Multisystem inflammatory syndrome in children
- Muromonab-CD3
- Myasthenia gravis
- Mycosamine
- Mycosis fungoides
- MYD88
- Myelitis
- Myelocytes
- Myeloid cells
- Myositis
- Myositis ossificans
- N-acetylglucosamine
- naive B cell
- Naive T cells
- Nanobody
- Natural killer cells
- Nephritis
- NeuN
- Neurocan
- Neurogenic inflammation
- Neuroimmune system
- Neuroimmunology
- Neurosarcoidosis
- Neutralizing antibody
- Neutrophil to lymphocyte ratio
- NFAT
- NGAL
- NK cells
- NKT cells
- NLRP4
- Nod like receptors
- Nod-like receptors
- Nonpuerperal mastitis
- Nonstructural proteins
- Nuclear bodies
- Nude mouse
- Ocular myasthenia
- Oedema
- Oesophagitis
- Omalizumab
- Oncostatin m
- Oophoritis
- Ophthalmia
- Opportunistic infections
- Oprelvekin
- Opsonin
- Opsonins
- Opsonization
- Optic neuritis
- ORF3b
- Osteitis
- Osteitis pubis
- Osteoclastogenesis
- Osteoclasts
- Osteoprotegerin
- Otilimab
- Overlap syndrome
- Ozogamicin
- Palivizumab
- Panel reactive antibody
- Panuveitis
- Paraneoplastic pemphigus
- Paratope
- Passive immunity
- Passive immunization
- Patch test
- Pathogen associated molecular pattern
- Pattern recognition receptors
- Perichondritis
- Perimyositis
- Periodic fever syndrome
- Periodontal disease
- Periodontitis
- Peripheral blood lymphocytes
- Peripheral blood mononuclear cells
- Peripheral tolerance
- Peripheral ulcerative keratitis
- Peritonitis
- Pexelizumab
- Peyer's patches
- Phagocytes
- Phlebitis
- Phlegmasia cerulea dolens
- Phlegmon
- Photoprotection
- Pidilizumab
- PIGR
- Pityriasis lichenoides
- Plaque reduction neutralization test
- Plasma cells
- Plasmacytoid dendritic cells
- Platelet factor 4
- Pleocytosis
- Pleomorphic T-cell lymphoma
- Pneumonitis
- Polyclonal antibodies
- Polyclonal antibody
- Polymeric immunoglobulin receptor
- Polymorphonuclear leukocytes
- Postviral fatigue syndrome
- Primary cutaneous marginal zone lymphoma
- Primary sclerosing cholangitis
- Proctitis
- Proinflammatory cytokines
- Prolymphocytes
- Promegakaryocyte
- Properdin
- Protegrin
- Protein subunits
- Proteolysis-inducing factor
- Pseudolymphoma
- Pulmonary alveolar proteinosis
- Pulpitis
- Pyelonephritis
- Quantiferon
- Racotumomab
- Radiobinding assay
- Ramucirumab
- RANKL
- RANTES
- Ravulizumab
- Raxibacumab
- RBP1
- RBP2
- Reactive gastropathy
- Receptor editing
- Recombinant antibodies
- Recombination signal sequences
- Recombination-activating gene
- Regulatory macrophages
- Regulatory T cells
- Reproductive immunology
- Reslizumab
- Respiratory burst
- Retinol binding protein 4
- Rho(d) immune globulin
- Rosai-Dorfman disease
- Sarilumab
- Scleroderma
- Secondary immune response
- Secretion assay
- Secretory component
- Self-protein
- Sentinel cells
- Serological tests
- Serology
- Serotypes
- Serum amyloid A
- Serum protein electrophoresis
- Sesamoiditis
- Sialadenitis
- Sialoadenitis
- Side-chain theory
- Siltuximab
- Simtuzumab
- Single chain variable fragment
- Sinus histiocytosis
- Skip lesions
- Smoker's macrophages
- Social immunity
- Solanezumab
- Somatic hypermutation
- Spartalizumab
- Sphingosine-1-phosphate receptor modulator
- Splenocytes
- Sterilizing immunity
- Stimulator of interferon genes
- Stomatitis
- Stromal cell-derived factor 1
- Superantigens
- Swollen glands
- Synovitis
- Systemic inflammation
- Systems immunology
- T cell
- T cell activation
- T cell deficiency
- T cells
- T helper cells
- T lymphocytes
- T-cell
- T-cell depletion
- T-cell growth factor
- T-lymphocytes
- Tendinitis
- Tendinopathy
- Tendinosis
- Tenosynovitis
- Th 9 cells
- Th1 cell
- Th17 cells
- Th2 cell
- Thymic epithelial cells
- Thymic involution
- Thymic stromal lymphopoietin
- Thymocytes
- Thymoglobulin
- Thymus
- Thymus gland
- Thyroid stimulating immunoglobulin
- Tildrakizumab
- Tissue-resident memory T cells
- Titer
- TLR5
- TNF inhibitor
- TNF receptor associated factor
- TNF-α
- TNFRSF1B
- Tolerogenic dendritic cells
- Toll like receptor 7
- Toll-like receptor 5
- Toll-like receptor 7
- Toll-like receptor 8
- Toll-like receptor 9
- Tonic immobility
- Tonsillitis
- Tositumomab
- Total complement activity
- Toxoids
- TRAF6
- Trained immunity
- Transfer factor
- Transitional B cells
- Transplant rejection
- Transverse myelitis
- Trif
- Trifunctional antibody
- Trinitrotoluene
- Trogocytosis
- Tumefactive multiple sclerosis
- Tumor infiltrating lymphocytes
- Tumor necrosis factor
- Tumor necrosis factor alpha
- Tumor necrosis factor receptor
- Tumor necrosis factor superfamily
- Tumour-necrosis factors
- Type 1
- Type 1 diabetes
- Type 1 diabetes mellitus
- Type 2 inflammation
- Type 3 innate lymphoid cells
- type I cytokine receptor
- Type III
- Ublituximab
- Uhthoff's phenomenon
- Unicentric Castleman disease
- Urelumab
- Urethritis
- Uropod
- Urosepsis
- Uterine natural killer cells
- Uveitis
- V(D)J recombination
- Vaginitis
- VDJ recombination
- Vedolizumab
- Veltuzumab
- Vernix caseosa
- Versican
- Vestibular neuronitis
- Viral nonstructural protein
- Viral vector vaccine
- Vitiligo
- Vogt-Koyanagi-Harada disease
- VPg
- Vpr
- Vulvovaginitis
- Water retention
- White blood cells
- Xanthogranulomatous
- ZMapp